PubMed

United States Food and Drug Administration Approval of Neurosurgical Devices: A 25-Year Review of Non-510(k) Pathway Trends.

PMID: 42419560 · 2026-07-08

A, n, d, r, e, w, , S, c, h, i, n, d, l, e, r, ;, , A, h, m, e, d, , A, b, d, o, u, ;, , P, a, r, t, h, , M, a, l, a, v, i, y, a, ;, , K, e, e, t, c, h, , M, e, c, h, a, m, ;, , S, a, m, u, e, l, , B, , K, a, n, k, a, m, ;, , P, a, r, a, s, , G, u, p, t, a, ;, , K, u, r, t, , Y, a, e, g, e, r

学術誌World neurosurgery

年2026-07-08

PMID42419560

抄録

Neurosurgical innovation increasingly relies on novel medical devices to advance the field. Low-risk devices follow the traditional 510(k) regulatory pathway for clearance; however, the U.S. Food and Drug Administration (FDA) offers other pathways; Premarket Approval (PMA), Humanitarian Device Exemption (HDE), De Novo, and Investigational Device Exemption (IDE) to provide market access for devices of different risk profiles. This study aims to provide the first characterization of non-510(k) neu

公式ソース

PubMedで見る →

データはPubMed / NCBIから取得しています。全文および最新情報は必ず公式記録をご確認ください。